United Guardian INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
United-Guardian, Inc. reported a 13% decrease in total sales for 2025, driven by a significant decline in cosmetic ingredient sales, while pharmaceutical and medical lubricant sales saw growth.
NASDAQ
United-Guardian, Inc. reports a 12% increase in sales and improved profitability for the fiscal year ended December 31, 2024, driven by strong performance in cosmetic ingredients.
NASDAQ
10-K: United-Guardian, Inc. Files 10-K Report, Details Financial Performance and Strategic Initiatives
United-Guardian, Inc. released its annual 10-K report, outlining its financial results for 2023, strategic shifts, and future outlook, including a focus on new product development and market expansion.